Debra A. Peattie
Private Equity Investor chez SV Investment Corp/US/
Profil
Debra A.
Peattie founded Valeo Medical, Inc. in 2003, where she worked as Chief Technology Officer from 2003 to 2009.
Dr. Peattie also currently works at SV Investment Corp, as Managing Partner from 2022.
Dr. Peattie also formerly worked at Epiphany Biosciences, Inc., as Director, GSK Plc, as Senior Director from 2013 to 2019, Harvard University, as Director-Business Development from 2011 to 2013, Office of Technology Development, as Director, Inhibitor Therapeutics, Inc., as Independent Director from 2019 to 2022, Valo Health LLC, as Executive director from 2019 to 2022, Cubist Pharmaceuticals LLC, as Principal, MPM BioImpact, Inc, as Principal, RCT BioVentures, as Principal, Harvard T.H.
Chan School of Public Health, as Professor, and RCT BioVentures NE LLC, as President from 1999 to 2003.
Dr. Peattie received her doctorate degree from Harvard University, undergraduate degree from Hollins University Corp., and Masters Business Admin degree from Harvard Business School.
Postes actifs de Debra A. Peattie
| Sociétés | Poste | Début |
|---|---|---|
| SV Investment Corp/US/ | Private Equity Investor | 01/01/2022 |
Anciens postes connus de Debra A. Peattie
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBITOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2022 |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Private Equity Investor | 01/01/2022 |
| GSK PLC | Private Equity Investor | 01/01/2019 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2013 |
Valeo Medical, Inc.
 Valeo Medical, Inc. Medical SpecialtiesHealth Technology Valeo Medical, Inc. develops non-invasive serum diagnostic for endometriosis, a chronic painful disease that affects women of child-bearing age. It products address the needs of millions of women who suffer with endometriosis. The company was founded by Frederick J. Fritz & Debra A. Peattie in 2003 and is located in Burlington, MA. | Fondateur | 03/11/2009 |
Formation de Debra A. Peattie
| Harvard University | Doctorate Degree |
| Hollins University Corp. | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| INHIBITOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Valeo Medical, Inc.
Valeo Medical, Inc. Medical SpecialtiesHealth Technology Valeo Medical, Inc. develops non-invasive serum diagnostic for endometriosis, a chronic painful disease that affects women of child-bearing age. It products address the needs of millions of women who suffer with endometriosis. The company was founded by Frederick J. Fritz & Debra A. Peattie in 2003 and is located in Burlington, MA. | Health Technology |
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Health Technology |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact LLC (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
RCT BioVentures NE LLC
 RCT BioVentures NE LLC Investment ManagersFinance RCT BioVentures NE LLC invests in companies located in the US and New England. The fund focuses on companies operating in the fields of life sciences and medical devices. It provides financing for early stage capital requirements with an investment size ranging from $500,000 - $750,000. | Finance |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Technology Services |
| SV Investment Corp/US/ | Finance |
